A blood test may help identify individuals at risk for Alzheimer’s before they show any signs of disease, according to a new study published in the journal Nature Medicine.

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the memory ...

No. The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

"New blood test gives very high accuracy to screen for Alzheimer's disease." ScienceDaily. ScienceDaily, 31 August 2023. <www.sciencedaily.com / releases / 2023 / 08 / 230831121807.htm>.

A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found. In comparison, neurologists and other ...

The advantage is that all of this can be done with a simple blood test long before any noticeable symptoms, says Dr. Mothaffar Rimawi, executive medical director of the Dan L. Duncan Comprehensive ...

Roche and Lilly are eying U.S. regulatory approval for the test. They are aiming to file clinical trial data with U.S. regulators in 2025, Bruce Jordan, leader of personalized healthcare solutions ...

A recent study published in Nature Medicine introduces a blood test targeting a specific insoluble form of tau—offering a potential breakthrough in how we approach Alzheimer's diagnostics.